Neonatal platelet function

Seminars in Thrombosis and Hemostasis

Volumn 29, Issue 4, 2003, Pages 363-371

  Israels, Sara J ^a,b   Rand, Margaret L ^c   Michelson, Alan D ^d  

^a University of Manitoba ^*  (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Neonates; Platelet function; Platelets

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADRENALIN; ALCOHOL; ALPHA 2 ADRENERGIC RECEPTOR; FIBRINOGEN; FIBRONECTIN; GLYCOPROTEIN IB; INDOMETACIN; NITRIC OXIDE; PROCOAGULANT; PROSTAGLANDIN SYNTHASE INHIBITOR; RISTOCETIN; THROMBIN; THROMBOXANE; THROMBOXANE RECEPTOR; VERY LATE ACTIVATION ANTIGEN 2; VON WILLEBRAND FACTOR;

BLEEDING; BLEEDING TIME; BRAIN HEMORRHAGE; CALCIUM MOBILIZATION; DEGRANULATION; DELIVERY; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; IN VITRO STUDY; LABOR; NEWBORN PERIOD; PHOSPHOLIPID METABOLISM; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION; UMBILICAL CORD BLOOD;

BLOOD PLATELET DISORDERS; BLOOD PLATELETS; HUMANS; INFANT, NEWBORN; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; SIGNAL TRANSDUCTION;

EID: 0042866015     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42587     Document Type: Review

References (103)

1. Andrew M, Paes B, Milner R, et al. The development of the human coagulation system in the full-term infant. Blood 1987;70:165-172
2. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651-1657
3. Andrew M, Schmidt B, Mitchell L, Paes B, Ofosu F. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost 1990;63:27-30
4. Andrew M, Brooker L, Leaker M, Paes B, Weitz J. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to low plasminogen concentration. Thromb Haemost 1992;68:325-330
5. Blanchette VS, Rand ML. Platelet disorders in newborn infants: diagnosis and management. Semin Perinatol 1997;21:53-62
6. Kuhne T, Imbach P. Neonatal platelet physiology and pathology. Eur J Pediatr 1998;157:87-94
7. Michelson AD. Platelet function in the newborn. Semin Thromb Hemost 1998;24:507-512
8. Beverly DW, Inwood MJ, Chance GW, Schaus M, O'Keefe B. "Normal" haemostasis parameters: a study in a well-defined inborn population of preterm infants. Early Hum Dev 1984;9:249-257
9. Andrew M, Kelton J. Neonatal thrombocytopenia. Clin Perinatol 1984;11:359-391
10. Patrick CH, Lazarchick J, Stubbs T, Pittard WB. Mean platelet volume and platelet distribution width in the neonate. Am J Pediatr Hematol Oncol 1987;9:130-132
11. Forestier F, Daffos F, Galacteros F, Bardakjian J, Rainaut M, Beuzard Y. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res 1986;20:342-346
12. Hohlfeld P, Forestier F, Kaplan C, Tissot JD, Daffos F. Fetal thrombocytopenia: a retrospective survey of 5194 fetal blood samplings. Blood 1994;84:1851-1856
13. Kipper S, Sieger L. Whole-blood platelet volumes in newborn infants. J Pediatr 1982;101:763-766
14. Arad ID, Alpan G, Sznajderman SD, Eldor A. The mean platelet volume (MPV) in the neonatal period. Am J Perinatol 1986;3:1-3
15. Clapp DW, Baley JE, Gerson ST. Gestational age-dependent changes in circulating hemopoietic stem cells in newborn infants. J Lab Clin Med 1989;113:422-427
16. Murray NA, Roberts IAG. Circulating megakaryocytes and their progenitors (BFU-MK and CFU-MK) in term and pre-term neonates. Br J Haematol 1995;89:41-46
17. Murray NA, Watts TL, Roberts IAG. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies. Pediatr Res 1998;43:148-151
18. De Alarcon PA, Graeve JL. Analysis of megakaryocyte ploidy in fetal bone marrow biopsies using a new adaptation of the Feulgen technique to measure DNA content and estimate megakaryocyte ploidy from biopsy specimens. Pediatr Res 1996;39:166-170
19. Miyazaki R, Ogata H, Iguchi T, et al. Comparative analyses of megakaryoctyes derived from cord blood and bone marrow. Br J Haematol 2000;108:602-609
20. Jilma-Stohlawetz P, Homoncik M, Jilma B, et al. High levels of reticulated platelets and thrombopoietin characterize fetal thrombopoiesis. Br J Haematol 2001;112:466-468
21. Peterec SM, Brennan SA, Rinder HM, Wnek JL, Beardsley DS. Reticulated platelet values in normal and thrombocytopenic neonates. J Pediatr 1996;129:269-274
22. Joseph MA, Adams D, Maragos J, Saving KL. Flow cytometry of neonatal platelet RNA. J Pediatr Hematol Oncol 1996;18:277-281
23. Kienast J, Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 1990;75:116-121
24. Ault KA, Rinder H, Mitchell J, Carmody MB, Vary CPH, Hillman RS. The significance of platelets with increased RNA content (reticulated platelets): a measure of the rate of thrombopoiesis. Am J Clin Pathol 1992;98:637-646
25. Sola MC, Juul SE, Li Y, et al. Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development. Early Hum Dev 1999;53:239-250
26. Watts TL, Murray NA, Roberts IAG. Thrombopoietin has a primary role in the regulation of platelet production in pre-term babies. Pediatr Res 1999;46:28-32
27. Sola MC, Calhoun DA, Hutson AD, Christensen RD. Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit. Br J Haematol 1999;104:90-92
28. Albert TSE, Meng YG, Simms P, Cohen RL, Phibbs RH. Thrombopoietin in the thrombocytopenic term and preterm newborn. Pediatrics 2000;105:1286-1291
29. Oygur N, Tunga M, Mumcu Y, et al. Thrombopoietin levels of thrombocytopenic term and preterm newborns with infection. Am J Perinatol 2001;18:279-286
30. Matsubara K, Baba K, Nigami H, et al. Early elevation of serum thrombopoietin levels and subsequent thrombocytosis in healthy preterm infants. Br J Haematol 2001;115:963-968
31. Traycoff CM, Abboud MR, Laver J, et al. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts? Blood Cells 1994;20:382-391
32. Sola MC, Du Y, Hutson AD, Christensen RD. Dose-response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non-thrombocytopenic neonates to recombinant thrombopoietin. Br J Haematol 2000;110:449-453
33. Ts'ao CH, Green D, Schultz K. Function and ultrastructure of platelets of neonates: enhanced ristocetin aggregation of neonatal platelets. Br J Haematol 1976;32:225-233
34. Suarez CR, Gonzalez J, Menendez C, Fareed J, Fresco R, Walenga J. Neonatal and maternal platelets: activation at time of birth. Am J Hematol 1988;29:18-21
35. Saving KL, Jennings DE, Aldag JC, Caughey RC. Platelet ultrastructure of high-risk premature infants. Thromb Res 1994;73:371-384
36. Saving KL, Aldag J, Jennings D, Caughey B, Regan M, Powers W. Electron microscopic characterization of neonatal platelet ultrastructure: effects of sampling techniques. Thromb Res 1991;61:65-80
37. Israels SJ, Daniels M, McMillan EM. Deficient collagen-induced activation in the newborn platelet. Pediatr Res 1990;27:337-343
38. Gruel Y, Boizard B, Daffos F, Forestier F, Caen J, Wautier JL. Determination of platelet antigens and glycoproteins in the human fetus. Blood 1986;68:488-492
39. Shenkman B, Linder N, Savion N, et al. Increased neonatal platelet deposition on subendothelium under flow conditions: the role of plasma von Willebrand factor. Pediatr Res 1999;45:270-275
40. Corby DG, O'Barr TP. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine. Dev Pharmacol Ther 1981;2:215-225
41. Davidson Ward SL, Schuetz S, Wachman L, et al. Elevated plasma norepinephrine levels in infants of substance-abusing mothers. Am J Dis Child 1991;145:44-48
42. Israels SJ, Odaibo FS, Robertson C, McMillan EM, McNicol A. Deficient thromboxane synthesis and response in platelets from premature infants. Pediatr Res 1997;41:218-223
43. Corby DG, Zuck TF. Newborn platelet dysfunction: a storage pool and release defect. Thromb Haemost 1976;36:200-207
44. Whaun JM. The platelet of the newborn infant: 5-hydroxytryptamine uptake and release. Thromb Diathes Haemorrhag 1973;30:327-333
45. Whaun JM. Platelet function in the neonate: including qualitative platelet abnormalities associated with bleeding. In: Stockman JA, Pochedly C, eds. Developmental and Neonatal Hematology. New York, NY: Raven; 1988:131-144
46. Qutob MS, Conway A, Stein DT, Ohler S, Lachant NA, Gunning WT. Dense granule number and adenine nucleotide content in umbilical cord platelets. Blood 2002;100:691a (Abst)
47. Mankin P, Maragos J, Akhand M, Saving KL. Impaired platelet dense granule release in neonates. J Pediatr Hematol Oncol 2000;22:143-147
48. Israels SJ, Gowen B, Gerrard JM. Contractile activity of neonatal platelets. Pediatr Res 1987;21:293-295
49. Andrew M, Castle V, Mitchell L, Paes B. Modified bleeding time in the infant. Am J Hematol 1989;30:190-191
50. Andrew M, Paes B, Bowker J, Vegh P. Evaluation of an automated bleeding time device in the newborn. Am J Hematol 1990;35:275-277
51. Katz JA, Moake JL, McPherson PD, et al. Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. Blood 1989;73:1851-1858
52. Weinstein MJ, Blanchard R, Moake JL, Vosburgh E, Moise K. Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura. Br J Haematol 1989;72:68-72
53. 2 with the length of the bleeding time. Clin Invest Med 1989;12:165-171
54. Kundu SK, Heilmann EJ, Sio R, Garcia C, Ostgaard RA. Characterization of an in vitro platelet function analyzer, PFA-100®. Clin Appl Thromb Hemost 1996;2:241-249
55. Favalaro EJ, Facey D, Henniker A. Use of a novel platelet function analyzer (PFA-100™) with a high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders. Am J Hematol 1999;62:165-174
56. Fressinaud E, Veyradier A, Truchaud F, et al. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998;91:1325-1331
57. Israels SJ, Cheang T, McMillan-Ward EM, Houston D. Comparison of the PFA-100® platelet function analyzer and the template bleeding time in evaluation of patients with a clinical bleeding history. Blood 1999;94(Suppl 1):452a (Abst)
58. Carcao MD, Blanchette VS, Dean JA, et al. The platelet function analyzer (PFA-100®): a novel in vitro system for evaluation of primary haemostasis in children. Br J Haematol 1998;101:70-73
59. Israels SJ, Cheang T, McMillan-Ward EM, Cheang M. Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr 2001;138:116-119
60. Roschitz B, Sudi K, Kostenberger M, Muntean W. Shorter PFA-100 closure times in neonates than in adults: role of red cells, white cells, platelets, and von Willebrand factor. Acta Paediatr 2001;90:664-670
61. Mull MM, Hathaway WE. Altered platelet function in newborns. Pediatr Res 1970;4:229-237
62. Corby DG, Schulman I. The effects of antenatal drug administration on aggregation of platelets of newborn infants. J Pediatr 1971;79:307-313
63. Corby DG, O'Barr TP. Neonatal platelet function: a membrane-related phenomenon? Haemostasis 1981;10:177-185
64. 2 production in whole blood: the effect of maternal low-dose aspirin. Br J Obstet Gynaecol 1994;101:203-208
65. Israels SJ, Andrew M. Neonatal haemostasis. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, eds. Haemostasis and Thrombosis. 3rd ed. Edinburgh, Scotland: Churchill Livingstone; 1994:1017-1055
66. Johnson SS, Montgomery RR, Hathaway WE. Newborn factor VIII complex: elevated activities in term infants and alterations in electrophoretic mobility related to illness and activated coagulation. Br J Haemotol 1981;47:597-606
67. Gatti L, Guarneri D, Caccamo ML, Gianotti GA, Marini A. Platelet activation in newborns detected by flow-cytometry. Biol Neonate 1996;70:322-327
68. Kuhne T, Ryan G, Blanchette V, et al. Platelet-surface glycoproteins in healthy and pre-eclamptic mothers and their newborn infants. Pediatr Res 1996;40:876-880
69. Rajasekhar D, Kestin AS, Bednarek FJ, Ellis PA, Barnard MR, Michelson AD. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 1994;72:957-963
70. Rajasekhar D, Barnard MR, Bednarek FJ, Michelson AD. Platelet hyporeactivity in very-low-birth-weight neonates. Thromb Haemost 1997;77:1002-1007
71. Hezard N, Amory C, Leroux B, Schlegel N, Potron G, Nguyen P. Platelet hyporeactivity in healthy children remains beyond the neonatal period. Blood 2002;100:69a (Abst)
72. Ichinose F, Uezono S, Muto R, et al. Platelet hyporeactivity in young infants during cardiopulmonary bypass. Anesth Analg 1999;88:258-262
73. Nicolini U, Guarneri D, Gianotti GA, Campagnoli C, Crosignani PG, Gatti L. Maternal and fetal platelet activation in normal pregnancy. Obstet Gynecol 1994;83:65-69
74. Grosshaupt B, Muntean W, Sedlmayr P. Hyporeactivity of neonatal platelets is not caused by preactivation during birth. Eur J Pediatr 1997;156:944-948
75. Irken G, Uysal KM, Olgun N, et al. Platelet activation during the early neonatal period. Biol Neonate 1998;73:166-171
76. Mannucci PM, Canciani T, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001;98:2730-2735
77. Tsai HM, Sarode R, Downes KA. Ultralarge von Willebrand factor multimers and normal ADAMTS13 activity in the umbilical cord blood. Thromb Res 2002;108:121-125
78. Schmugge M, Dunn M, Amankwah K, Blanchette VS, Freedman J, Rand ML. von Willebrand factor ultralarge multimers and the activity of the cleaving protease activity in healthy neonates and children. J Pediatr Hematol Oncol 2002;24:A14 (Abst)
79. Fischer BE, Thomas KB, Dorner F. von Willebrand factor: measuring its antigen or function? Correlation between the level of antigen, activity and multimer size using various detection systems. Thromb Res 1998;91:39-43
80. Linder N, Shenkman B, Levin E, et al. Deposition of whole blood platelets on extracellular matrix under flow conditions in preterm infants. Arch Dis Child 2002;86;127-130
81. Stuart MJ, Allen JB. Arachidonic acid metabolism in the neonatal platelet. Pediatrics 1982;69:714-718
82. Stuart MJ, Dusse J, Clark DA, Walenga RW. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine. Pediatr Res 1984;18:823-826
83. Stuart MJ, Oski FA. Vitamin E and platelet function. Am J Ped Hematol Oncol 1979;1:77-82
84. Brass LF, Manning DR, Cichowski K, Abrams CS. Signaling through G proteins in platelets: to integrins and beyond. Thromb Haemost 1997;78:581-589
85. Israels SJ, Cheang T, Robertson C, McMillan-Ward EM, McNicol A. Impaired signal transduction in neonatal platelets. Pediatr Res 1999;45:687-691
86. Gelman B, Setty BNY, Chen D, Amin-Hanjani SA, Stuart MJ. Impaired mobilization of intracellular calcium in neonatal platelets. Pediatr Res 1996;39:692-696
87. Michelson AD, Rajasekhar D, Bednarek FJ, Barnard MR. Platelet and platelet-derived microparticle surface factor V/Va binding in whole blood: differences between neonates and adults. Thromb Haemost 2000;84:689-694
88. Israels SJ, McMillan-Ward E. Neonatal platelet procoagulant activity. Blood 2002;100:78b (Abst)
89. Stuart MJ, Dusse J. In vitro comparison of the efficacy of cyclo-oxygenase inhibitors on the adult versus neonatal platelet. Biol Neonate 1985;47:265-269
90. Bleyer WA, Brekenridge RT. Studies on the detection of adverse drug reactions in the newborn II. The effects of prenatal aspirin on newborn hemostasis. JAMA 1970;213:2049-2053
91. Stuart MJ, Gross SJ, Elrad H, Graeber JE. Effects of acetyl-salicylic-acid ingestion on maternal and neonatal hemostasis. N Engl J Med 1982;307:909-912
92. Norton ME, Merrill J, Cooper B, Kullaer J, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329:1602-1607
93. Benigni A, Gregorini G, Frusca T, et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989;321:357-362
94. Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. Br Med J 2001;322:329-333
95. Unsworth J, d'Assis-Fonseca A, Beswick DT, Blake DR. Serum salicylate levels in a breastfed infant. Ann Rheum 1987;46:638-639
96. Ylikorkala O, Halmesmaki E, Viinikka L. Effect of ethanol on thromboxane and prostacyclin synthesis by fetal platelets and umbilical artery. Life Sci 1987;41:371-376
97. Cheung PY, Salas E, Schulz R, Radomski MW. Nitric oxide and platelet function: implications for neonatology. Semin Perinatol 1997;21:409-417
98. Varels AF, Runge A, Ignano LJ, Chandhuri G. Nitric oxide and prostacyclin inhibit fetal platelet aggregation: a response similar to that observed in adults. Am J Obstet Gynecol 1992;167:1599-1604
99. George TN, Johnson KJ, Bates JN, Segar JL. The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr 1998;132:731-734
100. Cheung PY, Salas E, Etches PC, Phillipos E, Schulz R, Radomski MW. Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates. Lancet 1998;351:1181-1182
101. Keh D, Kurer I, Dudenhausen JW, Woltmann W, Falke KJ, Gerlach H. Response of neonatal platelets to nitric oxide in vitro. Intensive Care Med 2001;27:283-286
102. Hoehn T, Krause MF, Buhrer C. Inhaled nitric oxide in premature infants - a meta-analysis. J Perinat Med 2000;28:7-13
103. Israels, SJ. Platelet function in the newborn. In: Michelson AD, ed. Platelets. San Diego CA: Academic; 2002:267-272